The DOI matches its Crossref record.
Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure
Abstract
Abstract. NGNGdimethyl-L-arginine (asymmetric dimethyl-L-arginine ADMA) and NGNG dimethyl-L-arginine (symmetric dimethyl-L-arginine; SDMA) are naturally occurring analogues of L-arginine, the substrate for nitric oxide (NO) synthesis. ADMA is a potent inhibitor of NO synthesis, and accumulates in the plasma of patients with renal failure. However the precise concentration of ADMA and SDMA in renal patients is still controversial. This study was performed to measure plasma ADMA and SDMA concentrations by two different HPLC techniques in nine healthy controls and 10 uraemic subjects, and to investigate the effects of haemodialysis. In controls, the mean (±SEM) plasma concentrations of ADMA and SDMA were 0.36±0.09 and 0.39±0.05 μmol/l respectively, yielding an ADMA/SDMA ratio of 1.2± 0.17. In uraemic patients, the plasma concentrations of ADMA and SDMA were 0.9±0.08 μmol/l (P<0.001 compared to controls) and 3.4±0.3 μmol/l (P<0.001 compared to controls) with an ADMA/SDMA ratio of 0.27±0.015 (P<0.001). In the course of one 4 h haemodialysis session, ADMA concentrations decreased from 0.99±0.13 to 0.77±0.3 μmol/l and SDMA concentrations from 3.38±0.44 to 2.27±0.21 μmol/l. The plasma ADMA/creatinine ratio tended to increase from 1.26±0.20 × 10−3 to 2.01±0.41 × 10−3 It is concluded that there is a modest (3-fold) but definite increase in plasma ADMA concentration in uraemic patients compared to controls. SDMA accumulates to a greater degree (8-fold increase) and more closely parallels creatinine concentration than ADMA. The change in the ADMA/SDMA ratio is not accounted for by greater renal or dialysis clearance of ADMA, and, even though alternative explanations are not excluded, greater metabolism of ADMA than SDMA is the most likely explanation. Although small in magnitude, the increase in ADMA concentration might be biologically significant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Endogenous Nitric Oxide Synthase Inhibitor: A Novel Marker of Atherosclerosis
Miyazaki, H., Matsuoka, H., Cooke, J. P., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T. (1999) · Circulation · doi:10.1161/01.cir.99.9.1141 · Cited by 756
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
Stühlinger, M. C. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 581
Does ADMA Cause Endothelial Dysfunction?
Cooke, J. P. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2032 · Cited by 581
Vallance, P., & Leiper, J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000128897.54893.26 · Cited by 553
Self-citation
Metadata
- Authors
- MacAllister, R. J., Rambausek, M. H., Vallance, P., Williams, D., Hoffmann, K.-H., & Ritz, E.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-12-01
- Volume
- 11
- Issue
- 12
- Pages
- 2449-2452
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2102049916
- Cited by
- 204
- References
- 0
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. https://app.cochat.ai/papers/10.1093/ndt/11.12.2449
- The paper
- MacAllister, R. J., Rambausek, M. H., Vallance, P., Williams, D., Hoffmann, K.-H., & Ritz, E. (1996). Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/11.12.2449
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.